Bausch + Lomb Corporation - Wutah dodolan YoY (TTM) BLCO

Annual sales revenue dynamics for four quarters were obtained from the GURU.Markets terminal with the metric value at 8.70. Bausch + Lomb Corporation (BLCO) is striving for global dominance by implementing innovations for cataract treatment. The corporation has built a closed ophthalmological ecosystem, tying clinics to its proprietary technologies. A broad product lineup allows the company to effectively resist pricing pressure from local manufacturers.
Bausch + Lomb - rincian analitis lan metrik utama (BLCO)

TTM sales growth measures the dynamics of total revenue over a rolling year, neutralizing seasonality and reporting gaps to identify the actual business expansion trend. For Bausch + Lomb Corporation (BLCO), this metric reflects the brand's ability to maintain its global positions in ophthalmology despite pricing pressure from competitors. By analyzing the annual revenue growth trend over a rolling 12-month period, an investor assesses the stability of the cash flow. Consistent growth confirms the company's fundamental strength and the reliability of its dividend payments.